ReviewPharmaceuticals (Basel, Switzerland)2026
Targeting the Ras-Ral Signaling Axis in Type 2 Diabetes Mellitus: A Dual-Modulation Approach to Correcting Insulin Resistance and β-Cell Dysfunction.
Narayanan Thulasi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.